Clinical Trial Update: Upregulation of Alpha-1 Receptors Upon Septic Shock? [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial investigating upregulation of alpha-1 receptors in septic shock has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Snippet

Sponsor: Direction Centrale du Service de Santé des Armées | Conditions: Septic Shock | Phase 2, Phase 3 | Status: TERMINATED